2007
DOI: 10.1542/peds.2006-3158
|View full text |Cite
|
Sign up to set email alerts
|

Growth and Neurodevelopmental Outcomes After Early Low-Dose Hydrocortisone Treatment in Extremely Low Birth Weight Infants

Abstract: BACKGROUND. Low cortisol concentrations in premature infants have been correlated with increased severity of illness, hypotension, mortality, and development of bronchopulmonary dysplasia. A total of 360 mechanically ventilated infants with a birth weight of 500 to 999 g were enrolled in a randomized, multicenter trial of prophylaxis of early adrenal insufficiency to prevent bronchopulmonary dysplasia. Mortality and bronchopulmonary dysplasia were decreased in the hydrocortisone-treated patients exposed to cho… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

7
104
0
1

Year Published

2009
2009
2021
2021

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 145 publications
(119 citation statements)
references
References 32 publications
7
104
0
1
Order By: Relevance
“…54,55 In a trial of postnatal hydrocortisone, chorioamnionitis was not associated with changes in the use of supplemental oxygen, bronchodilators or steroids at 18 to 22 months. 54 However, Kumar et al 55 recently reported an association between chorioamnionitis and both recurrent wheezing and physician-diagnosed asthma. This suggests that intrauterine exposure to inflammation may indeed have long-term adverse respiratory effects.…”
Section: Lungsmentioning
confidence: 99%
“…54,55 In a trial of postnatal hydrocortisone, chorioamnionitis was not associated with changes in the use of supplemental oxygen, bronchodilators or steroids at 18 to 22 months. 54 However, Kumar et al 55 recently reported an association between chorioamnionitis and both recurrent wheezing and physician-diagnosed asthma. This suggests that intrauterine exposure to inflammation may indeed have long-term adverse respiratory effects.…”
Section: Lungsmentioning
confidence: 99%
“…33,68 Data thus far are reassuring about long-term outcomes in preterm infants treated with hydrocortisone. 69,70 If hydrocortisone therapy is being considered for the extremely preterm infant with refractory hypotension, a blood specimen for cortisol should be obtained before initiating therapy. Pending that result, a test dose of 1 mg kg À1 can be given.…”
Section: Preterm Infantsmentioning
confidence: 99%
“…Patients exposed to long-term hydrocortisone therapy are likely to develop adrenal insufficiency secondary to hypothalamic-pituitary-adrenal axis suppression. Although there is evidence of neurodevelopmental impairment after prolonged use of hydrocortisone in ELBW infants (≤1000 gm) [54], the use of low dose hydrocortisone (1 mg/kg/day for 12 days followed by 0.5 mg/kg/day for 3 days) for the treatment of adrenal insufficiency in extremely low birth weight infants has not been found to be associated with an increased incidence of cerebral palsy [55].…”
Section: Long Term (≥2 Weeks)mentioning
confidence: 99%